Skip to content
Artwork for Flot.bio x Philip Hemme
Flot.bio x Philip Hemme · Dec 1, 2025 · 59 min

Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48

Why have early AI drug-discovery companies often overpromised but underdelivered? Biology is still complex and hard to solve, Werner told Philip in Vienna.We revisit Werner in Vienna after he left Evotec and went on a sabbatical in 2024. We talk about his new missions as FairJourney CEO and founder of WLAN Holdings, and discuss the global CDMO scene and Europe’s competitivity in biotech.And while it's still early days yet, we find out AI will transform the way we work in biopharma going forward, with new generations of companies shaping their business models around it. ⭐️ ABOUT THE SPEAKER Werner is the new CEO of FairJourney Biologics and invests with his holding. He served as CEO of Evotec from 2009 to 2024, expanding the company’s revenues and workforce. Prior to this, he was the CFO of Intercell in Austria for nine years. 🔗 LINKS MENTIONED WLAN Holding’s website - [](https://tiltbio.com/) https://wlanholding.com/ Werner Lanthaler, Evotec | Leading AI in Biotech | E02 -- https://flot.bio/episode/werner-lanthaler-evotec-ai-in-biotech/ Antoine Papiernik, Sofinnova | Billion Investing with Balance | E01 — https://flot.bio/episode/antoine-papiernik-sofinnova-ebillion-biotech-investing-with-balance/ Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39 — https://flot.bio/episode/alex-zhavoronkov-insilico-medicine-ai-drug-development-longevity/ 📜 TRANSCRIPT Read the full transcript here: https://flot.bio/episode/werner-lanthaler-biopharma-ai/ 📖 SHORT BLOGS BASED ON THIS EPISODE: Why AI in Biopharma Didn’t Live Up to the Hype: https://flot.bio/ai-drug-development/ 💸 DONATE We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme ⭐️ SPONSORSHIP Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts! 🫶 FOLLOW US Newsletter: http://eepurl.com/h_fnmH LinkedIn: https://www.linkedin.com/company/flot-bio/ X (Twitter): https://x.com/FlotBio 🙏 LIKE/FOLLOW/REVIEW Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below. 🎙️ABOUT FLOT.BIO Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free. ⏰ TIMESTAMPS [00:00:00] Intro [00:02:09] Werner Lanthaler: from Evotec to new roles [00:06:01] WLAN Holding and the benefits of a sabbatical [00:10:58] Inside the Evotec departure [00:13:13] Joining FairJourney Biologics [00:20:33] The job market in Europe [00:23:49] CDMO competition and China [00:28:07] Letting European biotech compete globally [00:34:50] How AI has overpromised in biopharma [00:48:09] Quick-fire questions

0:00-59:34

transcript

No transcript — this publisher did not publish one.

show notes

Why have early AI drug-discovery companies often overpromised but underdelivered? Biology is still complex and hard to solve, Werner told Philip in Vienna.We revisit Werner in Vienna after he left Evotec and went on a sabbatical in 2024. We talk about his new missions as FairJourney CEO and founder of WLAN Holdings, and discuss the global CDMO scene and Europe’s competitivity in biotech.And while it's still early days yet, we find out AI will transform the way we work in biopharma going forward, with new generations of companies shaping their business models around it.

⭐️ ABOUT THE SPEAKER

Werner is the new CEO of FairJourney Biologics and invests with his holding. He served as CEO of Evotec from 2009 to 2024, expanding the company’s revenues and workforce. Prior to this, he was the CFO of Intercell in Austria for nine years.

🔗 LINKS MENTIONED


📜 TRANSCRIPT

Read the full transcript here: https://flot.bio/episode/werner-lanthaler-biopharma-ai/


📖 SHORT BLOGS BASED ON THIS EPISODE:


💸 DONATE

We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme

⭐️ SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!

🫶 FOLLOW US

🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.

🎙️ABOUT FLOT.BIO


Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.

⏰ TIMESTAMPS


  • [00:00:00] Intro
  • [00:02:09] Werner Lanthaler: from Evotec to new roles
  • [00:06:01] WLAN Holding and the benefits of a sabbatical
  • [00:10:58] Inside the Evotec departure
  • [00:13:13] Joining FairJourney Biologics
  • [00:20:33] The job market in Europe
  • [00:23:49] CDMO competition and China
  • [00:28:07] Letting European biotech compete globally
  • [00:34:50] How AI has overpromised in biopharma
  • [00:48:09] Quick-fire questions
links11